Investors

Investor Presentation

Email Alerts

Stay informed and receive company updates straight to your inbox

Recent News

AXIM Biotechnologies CEO Issues Letter to Shareholders

  Summary: AXIM places strategic focus on commercializing FDA-cleared Dry Eye Disease (DED) diagnostic system Plans to address largely underserved DED diagnosis market with patent pending tear collection method and approved tests, supported by world-class DED...

Latest Annual Filing

Fiscal Year Ended Dec 31, 2020